Biography & Education

I endeavor to provide a holistic, thoughtful, and dedicated level of care to women with or at risk for gynecologic cancers and their families. As a gynecologic oncologist, I am fortunate to be in the unique position of being able to provide comprehensive, personalized care. Whether a condition calls for surgery, chemotherapy, or radiation treatment, I aim to be the primary care provider for a woman�s oncologic concerns. Having completed training in advanced surgical techniques (including robotic surgery), radical abdominal procedures, and cutting-edge research, my goal is to treat my patients with the most current, effective, and state-of-the-art treatment options available.
Position Summary Chirag Shah MD
Additional Information

Robotics 09/06

Dr. Shah was voted "Top Doctors" in Seattle Metropolitan Magazine.

Nearly 4,000 physicians, nurses and physician assistants in King, Kitsap and Snohomish counties nominated colleagues they would choose to treat themselves and their loved ones.

  • Gynecologic oncology
  • Robotic Surgery
Education Background
Medical School Indiana University
Residency University of Washington
Fellowship University of Washington
  • English
Professional Associations
Personal Interests
My wife Jennifer and I enjoy living in the beautiful Pacific Northwest with our three children. We are active and love the outdoors � hiking throughout the Northwest, spending time on Lake Washington whenever we can, and snowboarding here and in Colorado with Jennifer�s family. I also enjoy playing and watching most sports, including basketball and tennis, and can regularly be found in basketball league or pick-up games.

Care Locations

751 N.E. Blakely Dr.
Suite 3020
Issaquah, WA 98029
Fax 206-215-5953
747 Broadway
Seattle, WA 98122
751 N.E. Blakely Dr.
Issaquah, WA 98209
Pacific Gynecologic Specialists
1101 Madison Ave
Ste 1500
Seattle 98104
Fax (206)965-1735
Pacific Gynecology at Swedish Issaquah
751 NE Blakely Drive
Suite 3020
Issaquah 98029
Accepting Medicaid




  1. Shah CA, Brodsky M, Pomerantz R. The effect of progressive resistance strength training and nutritional supplementation on outcomes in the frail elderly. Jour Am Ger Soc. 48: 2000 Nov; S57.
  2. Im SS, Gordon AN, Buttin BM, Leath CA 3rd, Gostout BS, Shah CA, Hatch KH, Wang J, Berman ML. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol.105(1): 2005 Jan;35-41.
  3. Shah CA, Johnson B, Everett E, Tamimi H, Greer B, Swisher E, Goff B. Does size matter? Tumor size and morphology as predictors of nodal status and recurrence in endometrial cancer. Gynecol Oncol. 99(3): 2005 Dec; 564-570.
  4. Shah CA, Pizer E, Veljovich DS, Drescher CW, Peters WA, Paley PJ. Clear cell adenocarcinoma of the vagina in a patient with vaginal endometriosis. Gynecol Oncol. 103(3): 2006 Dec;1130-1132.
  5. Fox KV, Shah CA, Swisher EM, Garcia RL, Mandel LS, Swensen RE, Goff BA. An Evaluation of Cervical Cancer in Women Age Sixty and Over. Gynecol Oncol. 109(1): 2008 Apr:53-8.
  6. Shah CA, Allison KH, Garcia RL, Gray HJ, Goff BA, Swisher EM. Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer. Gynecol Oncol. 109(2): 2008 May: 215-9.
  7. Veljovich DS, Paley PJ, Drescher CW, Everett EN, Shah CA, Peters WA. Robotic Surgery in Gynecologic Oncology: Program initiation and outcomes after the first year with comparison to laparotomy for endometrial cancer staging. Am J Obstet Gynecol. 198(6): 2008 Jun: 679.e1-9.
  8. Lowe K, Shah CA, Wallace E, Anderson G, Paley P, McIntosh M, Anderson R, Scholler N, Bergan L, Thorpe J, Urban N, Drescher C. Personal Characteristics Influence Serum CA125, Mesothelin, and HE4 Levels in Healthy Post-Menopausal Women at Increased Risk for Ovarian Cancer. Canc Epid Biom Prev. 2008 Sep;17(9):2480-7
  9. Shah CA, Lowe K, Peters WA, Li CI, Goff BA. Factors Affecting Risk of Mortality in Women with Vaginal Cancer. Obstet Gynecol. 2009 May;113 (5)1038-45.
  10. Shah CA, Lowe K, Wallace E, Anderson G, Paley P, McIntosh M, Anderson R, Scholler N, Bergan L, Thorpe J, Urban N, Drescher C. The Influence of Ovarian Cancer Risk-Status on the Diagnostic Performance of the Biomarkers Mesothelin, HE4 and CA125. Canc Epid Biom Prev. 2009 May;18(5):1365-72.
  11. Gray HJ, Shah CA, Swensen RE, Tamimi HK, Goff BA. Alternative Intraperitoneal Chemotherapy Regimens for Optimally Debulked Ovarian Cancer. Gynecol Oncol. 2010 Mar; 116 (3)340-4.

Should a robot perform your surgery?

September 28, 2011

Robotic surgery - the term implies some futuristic concept, a la the “Jetsons” or Isaac Asimov. As someone who was a science fiction fan growing up, I never thought I’d actually spend every day of my professional life answering this question.

As a gynecologic oncology surgeon, this is a question I now ask myself every time I pick up a patient’s chart. And the answer more times than not is YES! Why?



  • Gynecologic oncology
  • Robotic Surgery
Clinical Interests
  • Abdominal Surgery
  • Cervical Cancer
  • da Vinci (Robot-Assisted Surgery)
  • Endometrial Cancer
  • Endometriosis
  • Gynecologic Cancer
  • Gynecologic Oncologists
  • Gynecologic Oncologists
  • Gynecologic Oncologists cervix ovarian and uterus
  • Hysterectomy (Robotic)
  • Ovarian Cancer
  • Pelvic Prolapse
  • Pelvic Surgery
  • Surgeons
  • Vaginal Cancer
  • Vaginal Hysterectomy
  • Vaginal Sling Procedure
  • Vaginal Surgery
  • Vulvar Cancer